معرفی
Z. Ping Lin is a Research Scientist in the Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. His work focuses on ovarian cancer, integrating DNA repair mechanisms, cell cycle regulation, and drug discovery to develop targeted therapies.
- Education: PhD (2003) from Yale University School of Medicine; BS (1999) from George Washington University Medical Center; BS (1991) from Taipei Medical College.
Dr. Lin's research bridges molecular biology and pharmacology to address challenges in ovarian cancer treatment. Key areas include DNA repair pathways, cell cycle regulation, and apoptosis, with applications in metastasis and immune evasion. His work extends to high-throughput screening for novel therapeutics.
The articles highlight trends in computational biology for drug discovery, molecular oncology targeting resistance mechanisms, and genomic approaches to improve cancer prognosis. Recent studies focus on machine learning models for survival outcomes and kinase inhibitors in gynecologic cancers.
Collaborations with researchers like Elena Ratner and Yang Yang underscore interdisciplinary efforts in ovarian cancer. Dr. Lin's contributions include preclinical studies on Poly (ADP-ribose) polymerase (PARP) inhibitors and ribonucleotide reductase regulation.
